Koers Edwards Lifesciences Corporation Börse Stuttgart
Aandelen
EWL
US28176E1082
Geavanceerde medische apparatuur & technologie
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
82,68 EUR | +4,06% | +1,56% | +14,69% |
Omzet 2024 * | 6,56 mld. 6,03 mld. | Omzet 2025 * | 7,2 mld. 6,62 mld. | Marktkapitalisatie | 52,1 mld. 47,89 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,62 mld. 1,49 mld. | Nettowinst (verlies) 2025 * | 1,86 mld. 1,71 mld. | EV/omzet 2024 * | 7,68 x |
Nettoliquiditeiten 2024 * | 1,7 mld. 1,56 mld. | Nettoliquiditeiten 2025 * | 2,89 mld. 2,65 mld. | EV/omzet 2025 * | 6,83 x |
K/w-verhouding 2024 * |
32,5
x | K/w-verhouding 2025 * |
28,1
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 91,59% |
Recentste transcriptie over Edwards Lifesciences Corporation
1 week | +1,56% | ||
Lopende maand | +0,40% | ||
1 maand | -6,20% | ||
3 maanden | -0,85% | ||
6 maanden | +30,99% | ||
Lopend jaar | +14,69% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 01-01-15 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 01-01-14 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 05-07-16 |
Chairman | 67 | 13-11-14 | |
Steven Loranger
BRD | Director/Board Member | 72 | 16-03-16 |
Datum | Koers | Variatie |
---|---|---|
15-05-24 | 82,34 | +3,62% |
14-05-24 | 79,46 | +0,94% |
13-05-24 | 78,72 | -2,83% |
10-05-24 | 81,01 | +2,90% |
09-05-24 | 78,73 | -0,40% |
uitgestelde koers Börse Stuttgart, 15 mei 2024 om 20:52 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+13,01% | 227 mld. | |
+13,77% | 192 mld. | |
+18,13% | 136 mld. | |
+28,33% | 108 mld. | |
+1,67% | 64,07 mld. | |
+7,04% | 51,87 mld. | |
+10,79% | 44,33 mld. | |
+6,08% | 36,75 mld. | |
+28,42% | 31,71 mld. |